Table 5: Distribution of screen-detected and clinically detected CRC according to tumor site and gender.

Tumor siteScreen-detected CRCInterval CRC (≤30 months) Clinically diagnosed CRC >30 months
Men Women Men WomenMen Women
(%) (%) (%) (%) (%) (%)

Proximal13 (20.0)10 (31.3) 8 (19.5) 7 (36.8)16 (37.2) 12 (44.4)
Distal37 (56.9)19 (59.4)14 (34.1)6 (31.6)14 (32.6)10 (37.0)
Rectum15 (23.1)3 (9.4)19 (46.3) 6 (31.6)13 (30.2) 5 (18.5)

Men versus women in screen-detected CRC: = 3.34, ; men versus women in interval CRC (≤30 months): = 2.26, ; men versus women in clinically-diagnosed CRC >30 months: = 1.20; .